Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis
DiscussionAntiplatelet –HTPR may predict risks of recurrent vascular events/outcomes in CVD patients. Given the heterogeneity between studies, further prospective, multi-centre studies are warranted.
Source: Journal of Neurology - Category: Neurology Source Type: research
More News: Aspirin | Brain | Clopidogrel | Databases & Libraries | Disability | Heart Attack | Ischemic Stroke | Neurology | Plavix | Stroke | Study